(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MEDICAMENTO CONTRA CÂNCER OU AIDS

ArquivadaInvention Patent

Application data

Number

PI9203302

Type

Invention Patent

Filing

08/24/1992

Publication

03/30/1993

Progress at the INPI

  1. Filing08/24/92
  2. Publication03/30/93
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 08/24/1992 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 03/20/2018. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

J. B. (pessoa física)

AU

Inventors

J. B. (pessoa física)

AU

Technical data

IPC Classification

Priority claims

DE

P 41 28 625.1 · 08/26/1991

Abstract

Uso de nicotinamida-adenina-dinucleotídio (NADH), nicotinamida-adenina-dinucleotídio-fosfato (NADPH) ou seu sal fisiologicamente compatível para o tratamento de câncer ou AIDS.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Republicação - classificação IPC

#15.11

Procedimento automático de reclassificação. A classificação IPC anterior era A61K 37/50.

03/20/2018

RPI 2463

Arquivamento - Art. 33 da LPI

#11.1

10/03/1995

RPI 1296

Publicação do pedido de patente

#3.1

03/30/1993

RPI 1165

Pedido de patente depositado

#2.1

09/29/1992

RPI 1139

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.